Mr Robert Dickey IV

Robert Dickey serves as Chief Financial Officer of Onconox, bringing more than 30 years of financial and operational leadership experience across public, private, and development-stage life science companies. He has held multiple C-level and board positions guiding strategic finance, investor relations, and corporate development, including at Dendreon, Asterias Biotherapeutics, and Neuraptive Therapeutics. Robert has extensive expertise in fundraising, IPO execution, M&A, and financial governance within biotech and medtech environments. At Onconox, he oversees financial strategy, capital structure, and investor engagement, ensuring disciplined growth as the company advances its clinical and platform milestones.